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Cellular homeostasis is linked tightly to mitochondrial functions. Some damage to mitochondrial
proteins and nucleic acids can lead to the depolarization of the inner mitochondrial membrane,
thereby sensitizing impaired mitochondria for selective elimination by autophagy. Mitochondrial
dysfunction is one of the key aspects of the pathobiology of neurodegenerative disease. Parkin,
an E3 ligase located in the cytosol and originally discovered as mutated in monogenic forms of Par-
kinson’s disease (PD), was found recently to translocate speciﬁcally to uncoupled mitochondria and
to induce their autophagy.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Mitochondria and mitochondrial autophagy, mitophagy
One of the cellular organelles, mitochondria, can be paraphrased
as a master regulator for the life of cell, due to mitochondrial func-
tions in energy consumption and promotion of cell death, apoptosis
[1]. Recent work on the biology of the autophagy has demonstrated
that autophagy is one of the regulating mechanisms for mitochon-
drial quality control, especially as an active mechanism for elimina-
tion of damaged or excess mitochondria from the cell [2–4].
Recent studies on mammalian systems have suggested that
mitochondrial elimination by autophagy is essential for variety cel-
lular events, including the maturation of erythroid cells [5–7] and
the maintenance of neuronal tissues, which may be targeted in
neurodegenerative diseases [8]. Mitochondria also have a risk of
causing normal cell dysfunction at any time due to problems, such
as oxidative stress [9] or mutations in the mitochondrial genome
[10], occurring along the metabolic pathway mediated by mito-
chondrial respiratory chain complexes. Thus, mitochondria need
to remain functional by several mechanisms since the function is
tightly linked to the homeostasis of cells (Fig. 1). Cells may com-
pensate for mitochondrial defects by the function of antioxidant
enzymes, DNA repair, or complementing the damage through the
fusion of a healthy mitochondrion with a damaged mitochondrion.lf of the Federation of European BiAlternatively, proteins on the damaged mitochondria may be
selectively degraded [11]. Furthermore, in order to prevent the
problem of unsalvageable damaged mitochondria spreading within
the cell, there is a mechanism to eliminate the dysfunctional mito-
chondria by autophagy, called mitophagy [2–4].
Mitophagy was originally found under starvation conditions,
which are a trigger for the bulk autophagy process. Bulk autophagy
captures cytoplasmic components simultaneously, and then de-
grades them to recycle amino acids resources. Organelle speciﬁc
mitophagy can be seen in the maturation process of erythroid cells,
which requires mitochondrial elimination. Although some observa-
tions suggest thepresenceof theeliminationsystemfor thisdynamic
organelle, the molecular mechanisms are poorly understood [12].
Recent works [4,13–16] explore how the maintenance of a func-
tional mitochondrial network, i.e. mitochondria quality control
[17], is mediated by Parkin, which is an E3 ligase originally discov-
ered as mutated in monogenic forms of Parkinson’s disease (PD)
[18]. Parkin is working to selectively recognize and eliminate dam-
aged mitochondria from the cell by autophagy [4]. These ﬁndings
illuminate the possibility of clinical application by providing a
working model for the pathological state of PD.2. Mitochondrial dysfunctions and Parkinson’s disease
PD is one of the neurodegenerative diseases characterized by
degeneration of dopaminergic neurons of the substantia nigra inochemical Societies.
Fig. 1. Mitochondria suffer cellular stress and require the maintenance systems. Many stress generated from inner (mtDNA mutations, deletions) or outer (oxidative stress,
toxins) of mitochondria damage mitochondrial functions. If mitochondria failed to maintain their functions by their maintenance system, mitochondria proceed to
dysfunctional state. Dysfunctional mitochondria should be eliminated by autophagy system, named mitophagy.
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movement dysfunctions [19]. A relationship between mitochon-
drial dysfunction and neurodegenerative disorders has been
suggested in numerous studies, especially for PD [20]. The dysfunc-
tion of mitochondria in PD patients or PD animal models is due
to at least one of the following: deletion of mitochondrial DNA,
accumulation of mitochondrial DNA mutations [10] or the increase
of oxidative stress from reactive oxygen species (ROS) which is
generated through the mitochondria-mediated metabolic path-
ways [9]. Further demonstrating the relationship between mito-
chondrial function and PD, some of the chemical toxins that
induce parkinsonism [21] are inhibitors of the mitochondrial respi-
ratory chain complexes. Additional evidence for a link between PD
and mitochondria is supported by molecular studies using PD-
associated genes (PARK genes) products. Some of the PD-associated
gene products are located on or linked to mitochondria [22,23],
especially PINK1 (PARK6) and Parkin (PARK2). A Drosophila model
using pink1 and parkin strains has been thoroughly characterized
[24–30]. Mutant ﬂy strains of pink1 and parkin phenocopy one an-
other with phenotypes including the disruption of dopaminergic
neurons and swollen mitochondrial morphology. Recent work sug-
gests that PINK1 and Parkin function in the same pathway for the
maintenance of mitochondrial integrity [24–26]. From genetic
approaches, it was revealed that PINK1 functions upstream of
Parkin in the regulation of mitochondrial dynamics [27–30].
Taken together, these lines of evidence demonstrate that the
relationship between mitochondrial dysfunction and PD-patholog-
ical mechanism strongly suggests that the accumulation of mito-
chondrial damage might cause PD pathogenesis; however, the
detailed mechanisms are not completely understood.
3. Cellular localization and function of Parkin
PARK2, an autosomal recessive-juvenile PD (AR-JP)-causing
gene, was identiﬁed from Japanese patients with PD [18], and it
is now known to be the causative gene in 10–15% of juvenile Par-
kinson’s disease. PARK2 gene encodes Parkin, which is an E3 ubiq-uitin ligase [31]. Since many substrate proteins in various
subcellular locations are ubiquitinated by Parkin [32], there was
no uniﬁed theory on the cellular localization of Parkin. Based on
the idea that Parkin functions in the maintenance of mitochondrial
integrity, we compared mitochondria in a healthy state to those in
a damaged state induced by a chemical reagent, CCCP (carbonyl
cyanide m-chlorophenyl hydrazone), which causes depolarization
of mitochondria. Surprisingly, Parkin had drastic accumulation on
the depolarized, fragmented mitochondria [4]. Parkin can be selec-
tively recruited to individual electrochemically compromised
mitochondria, which display greater Parkin accumulation than
electrochemically active mitochondria (Fig. 2). This ﬁnding led to
the hypothesis that impaired mitochondria are selectively targeted
by Parkin [4].
It was unclear whether mitochondrial depolarization or the
fragmentation that results from the depolarization was the signal
for the translocation of Parkin to the mitochondria. Since these oc-
cur very close in time, we addressed the role of fragmentation
alone. To cause fragmentation without mitochondrial depolariza-
tion in HeLa cells stably expressing YFP-Parkin, we overexpressed
vMIA (viral mitochondrial inhibitor of apoptosis), a human cyto-
megalovirus structural protein that fragments mitochondria with-
out inducing mitochondrial depolarization [33]. YFP-Parkin in
these cells did not show mitochondrial localization, suggesting
that mitochondrial fragmentation alone does not induce Parkin
translocation. Next, we addressed if mitochondrial depolarization
without fragmentation could target Parkin to the mitochondria.
We used overexpression of Drp1Lys38Ala [34] (a mutation in dyn-
amin-related protein 1, Drp1, which causes a inhibition of mito-
chondrial division) to block mitochondrial division and then
induced mitochondrial depolarization with CCCP (Fig. 2). Even in
the absence of mitochondrial fragmentation, YFP-Parkin accumu-
lated on the elongated mitochondria treated with CCCP. Taken to-
gether these results indicate that mitochondrial depolarization, but
not fragmentation, is a signal for Parkin translocation to the mito-
chondria. Since CCCP also induces the disruption of a chemical po-
tential (DpH) of mitochondria, we further examined the condition
Fig. 2. Parkin selectively translocates to the depolarized mitochondria. (a) Under normal conditions (left), most of the Parkin (green) is in cytosol, whereas some (arrows) are
found on the fragmented mitochondria (red). When mitochondria were depolarized by CCCP (right), the cytoplasmic Parkin accumulated on the fragmented mitochondria.
HEK293T cells, scale: 5 lm. (b) In HeLa cells expressing YFP-Parkin, Parkin also accumulated on depolarized and fragmented mitochondria after CCCP treatment (right). Scale:
1 lm. (c) Only mitochondrial fragmentation by vMIA expression, whereas mitochondria maintain their membrane potential, does not signal for the Parkin translocation (left).
Mitochondria blocked their division by Drp1K38A recruit YFP-Parkin upon depolarization (right). HeLa cells, scale: 1 lm. (d) Mitochondria in MEF cells derived fromMfn1/,
Mfn2/ [53] mice, which are showing heterogenic mitochondrial membrane potential. Cytochrome-c (Cyt c) immunostaining indicates total mitochondrial images in a cell,
Mitotracker Red (MTR) indicates polarized (healthy, arrowhead) mitochondria. YFP-Parkin accumulates only on depolarized (Mitotracker red-negative, damaged)
mitochondria (arrows). Images are adapted from [4].
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sipates membrane potential loss, but not DpH, recruits Parkin onto
mitochondria, whereas nigericin, which lowers pH but not mem-
brane potential, does not recruit Parkin onto mitochondria [13].
These evidences also indicate that the translocation of Parkin is
strictly regulated in a response to the electrochemical conditions
of the mitochondria.
What is the function of Parkin after translocation to damaged
mitochondria? If the idea that Parkin mediates the maintenance
of mitochondrial integrity is true, Parkin may translocate to the
damaged mitochondria to eliminate problems. Healthy mitochon-
dria create ATP by the respiratory chain complexes during which
they generate the membrane potential. Membrane potential is
indispensable to the membrane structure and the functional main-
tenance of mitochondria, disruption of the membrane potential re-
sults in mitochondrial fragmentation [35]. Recent work by Twig
et al. demonstrated that a subpopulation of depolarized and frag-
mented mitochondria that are removed from the mitochondrial
network, are captured by autophagosomal structures which then
undergo the autophagosomal/lysosomal cellular digestion system
[3]. Indeed, after Parkin translocation to the damaged mitochon-
dria, Parkin-labelled mitochondria could be eliminated from cells
through an autophagy/lysosome dependent manner [4]. Co-locali-
zation of mitochondria and autophagosomes was found under
mitochondrial depolarization conditions in cells expressing Parkin.
In cells not expressing Parkin, most cells had little co-localization
between mitochondria and autophagosomes (Fig. 3). Parkin may
promote autophagosome recruitment to Parkin-labelled mitochon-
dria, which are depolarized and likely have accumulated damages.
These autophagosomes, which include Parkin-labelled mitochon-
dria, proceed to the lysosomes to be degraded. This sequential pro-cess was signiﬁcantly blocked by the addition of autophagosome or
lysosome inhibitors. Furthermore, Parkin failed to eliminate depo-
larized mitochondria [4] in mouse embryonic ﬁbroblasts derived
from ATG5 gene knockout mice [36], which due to the elimination
of the key component, Atg5, in the autophagy process cannot form
autophagosomes. From all of these results, it was clear that the
mechanism for the selective, Parkin-mediated elimination of dam-
aged mitochondria is autophagy-dependent.
4. Remaining questions and perspective
Others and we have conﬁrmed experiments identifying the
mechanisms of Parkin-mediated selective mitophagy in mamma-
lian system [4,13–16]; (1) Parkin has the ability to speciﬁcally rec-
ognize and localize to the damaged mitochondria, and (2) Parkin
localized on damaged mitochondria induces the elimination of
mitochondria using autophagy (mitophagy). The molecular mech-
anism of mitochondrial quality control (QC) mediated by Parkin is
intriguing, especially when considering the perspective of the rela-
tionship between neurodegenerative disorders and mitochondria.
The point to emphasize here is not the mitochondrial elimina-
tion by means of bulk autophagy previously observed in the starva-
tion-state in which cytoplasmic components were simultaneously
taken up (bulk mitophagy), but rather the key point is that Parkin
induces the speciﬁc elimination of damaged mitochondria (selec-
tive mitophagy). This likely explains the signiﬁcation of mitochon-
drial dysfunction and the increase in intracellular oxidative stress
in PD patients and animal model. What is the signiﬁcance of Par-
kin-mediated elimination of damaged mitochondria from the cell?
We propose that Parkin naturally contributes to protection of the
cell from the adverse effects of the intracellular spread of damaged
Fig. 3. Parkin eliminates damaged mitochondria. (a) After (1 h) mitochondrial depolarization with CCCP, mitochondria (right) are surrounded by Parkin (center) and
autophagosomes (LC3, left). (b) The recruitment of autophagosomes to mitochondria is induced by Parkin. In the absence of Parkin expression (left), depolarized mitochondria
(red) are not associated with autophagosomes (LC3, green), whereas autophagosomes are more associated with mitochondria in the presence of Parkin (right). Scale: 1 lm. (c)
After (48 h) mitochondrial depolarization with CCCP, mitochondria are not detectable with immunostaining. Only cells expressing YFP-Parkin (left), mitochondria (right) are
completely eliminated. (d) After (48 h) mitochondrial depolarization with CCCP, mitochondria were taken up by lysosomes only in the HeLa cells expressing YFP-Parkin
(right). Scale: 500 nm. Images are adapted from [4].
Fig. 4. Working model for the Parkin-mediated mitochondrial quality control. Depolarized mitochondria are sensed by Parkin. After Parkin recruitment to the damaged
mitochondria (PINK1 dependent), Parkin may ubiquitinate some substrates to degrade or tagging to proceed following process. After translocation, Parkin also recruits
autophagosomes to promote mitophagy.
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within the cell (Fig. 4). Further supporting a protective function for
Parkin, there are also reports that increasing the intracellular over-
expression of Parkin suppresses cell death [37–39]. Parkin could
protect preemptively against cell death, the worst scenario for a
cell, by keeping the cell healthy through mitochondrial quality
control. However, further studies described as followed for the in-
sight of mitophagy are still on going and required.
4.1. Translocation mechanism of Parkin
For the mechanism of Parkin translocation to mitochondria, it
has been shown that PINK1 overexpression induces Parkin translo-
cation [30]. As mentioned above, PINK1 and Parkin function to-
gether in a same pathway to maintain mitochondrial integrity. It
is logical that if PINK1, which localizes to mitochondria and func-
tions upstream of Parkin, might be required for the Parkin function,speciﬁcally translocation to damaged mitochondria. Very recent
interesting works are predicting this point [14–16,30]. These
groups found independently that PINK1 is required for the Parkin
recruitment to mitochondria. Moreover, PINK1 overexpression suf-
ﬁces to recruit Parkin to mitochondria with normal membrane po-
tential. These observations are suggesting that the physical
interaction of PINK1 and Parkin promotes the redistribution of Par-
kin from the cytosol to the mitochondria.
4.2. Parkin as an E3 ubiquitin ligase
Many patient mutations within the PARK2 (Parkin) gene cause a
decrease or complete loss of E3 ubiquitin ligase activity of Parkin
protein [40]. In the animal model for PD deletion of PARK2 causes
mitochondrial dysfunction and the increase of oxidative stress.
To link this evidence to ubiquitin ligase activity of Parkin and
Parkin-mediated mitophagy, we also can expect that some
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didate for mitochondrial substrate comes from Drosophila studies
[27–29]. The mutant strains of parkin or pink1 can be partially
complemented by the suppression of mitochondrial fusion pro-
teins, such as Opa1 and Mitofusin/Marf. This suggests that the
pro-ﬁssion state of mitochondria is required for mitophagy and
that Parkin can ubiquitinate and degrades these mitochondrial fu-
sion proteins. Thus, a PINK1/Parkin pathway may regulate mito-
phagy process by changing mitochondrial dynamics [17],
especially forcing mitochondria to an excessive ﬁssion state, which
allows mitochondria to be captured by autophagosomes. More-
over, recent work supports this idea by demonstrating that the ﬁs-
sion of mitochondria is required for the autophagic degradation of
mitochondria [3]. Conﬂicting with above, it was shown that the
suppression of PINK1 results in the fragmentation of mitochondria
[41] and induces mitochondrial autophagy, however we suggest
based on an our working model that loss of PINK1 or Parkin func-
tion exacerbates accumulation of mitochondrial damage, due to
defective removal of damaged mitochondria, and the ensuing
excessive damage results in mitochondrial fragmentation.
4.3. Autophagosomes recruitment to the damaged mitochondria
Although we clearly showed that autophagic structures are re-
cruited to Parkin-labelled, damaged mitochondria, the molecular
mechanism of this is still unknown. Targeting of ubiquitin onto
organelle or inclusion bodies surface is sufﬁcient to recruit auto-
phagic structures [42–44], and it has been suggested that p62 acts
as a bridging protein between the ubiquitinated proteins/struc-
tures and autophagosomes. A recent work suggests that p62 may
involve with Parkin-mediated clearance of the depolarized mito-
chondria; cells silenced p62 expression decrease the mitochondrial
clearance upon depolarization [15]. Further prediction proposed byFig. 5. Working model for the Pathogenesis of PD. The vital mitochondrial network is m
states of PD, cellular stress or damage cause the excess of damaged mitochondria, then
accumulates damaged mitochondria (bottom). Both pathological states may cause the cVives-Bauza et al. suggests that PINK1/Parkin-mediated damaged
mitochondria clearance is regulated by transportation of damaged
organelles to the lysosomes in a microtubule dependent manner
[14]. Since many evidences are suggesting the sequential steps of
mitochondrial clearance by PINK1/Parkin pathway followed by
autophagic pathway, we still poorly understand the molecular
mechanisms. Parkin ubiquitinates various substrates not only for
the degradation by ubiquitin-proteasome pathway, but also for
signal transduction [32]. Most ubiquitinated proteins that are de-
graded by the proteasome system are tagged by Lys48 type ubiqui-
tin chains, whereas ubiquitinated proteins that have a Lys63 linked
ubiquitin function in signal transduction [45]. Based on our ﬁnd-
ings, Parkin may function simultaneously to ubiquitinate mito-
chondrial dynamics proteins to induce pro-ﬁssion state by Lys48
ubiquitination and degradation, and tagging for the autophago-
somes recruitment by Lys63 ubiquitination of unidentiﬁed mito-
chondrial proteins. More experiments are required to distinguish
what role the Parkin-mediated ubiquitination plays in mitophagy.
4.4. Lessons from mitochondrial elimination by other pathways
Studies in yeast identiﬁed autophagy-related genes (ATG genes)
and uncovered the mechanisms of several types of autophagy pro-
cess; macroautophagy for non-selective autophagy, cytoplasm to
vacuole targeting (Cvt) pathway, pexophagy, and mitophagy for
selective autophagy of several proteins or organelles [46]. Very re-
cent studies with excellent genetic screens by Okamoto et al. and
Kanki et al. identiﬁed independently a mitophagy-related gene in
yeast, named ATG32 [47,48]. Atg32 protein is identiﬁed as an outer
mitochondrial membrane protein, and a receptor molecule for
Atg11 proteins, which is a key component for the recruitment of
preautophagic structures (PAS) tomitochondria. Atg32alsocontains
a conservedWXXI/L/Vmotif for the interactionwith Atg8, which is aaintained by the quality control (QC) system (top, also see in Fig. 1). In pathological
overwhelm the QC system (middle). Disruption of mitochondrial QC system also
ollapse of the cellular environment following by the cell death.
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Mammalianp62protein also contains thismotif to interactwith LC3.
Thus, these lines of evidence suggest that yeast and mammal may
share common components for the selective mitophagy, although
any mammalian homologue of yeast Atg-proteins for the selective
mitophagy have not yet been identiﬁed. Recent studies reported that
an outermitochondrial membrane protein Nix/BNIP3 is required for
the selectivemitochondrial elimination in an autophagy-dependent
manner during mammalian reticulocytes maturation [5–7]. Thus
Nix/BNIP3 may represent a functional homologue or a counterpart
for Atg32, whereas many details in the process of mitophagy in
mammalian system are still open to future studies.
4.5. Endogenous mitophagy: ‘‘Does Parkin allow cells to survive by
maintaining mitochondrial quality?”
Mitochondria can promote cell death by initiating apoptosis. If
cell had a serious problem that could not be resolved by autophagy,
they could execute cell suicide by apoptosis to prevent the inﬂam-
mation of entire tissues. What would be the case for a tissue that
cannot choose cell death? One key example would be differentiated
nerve cells. In patients with PD the lack of dopaminergic neurons in
the substantia nigra is probably due to the relative stress placed on
the mitochondria by the generation of reactive oxygen species as a
byproduct in the dopaminergic route of these neurons [49] and/or
the resulting toxicity of the mutated Parkin protein, which may
form aggregates in the cytoplasm itself [50]. This increased stress,
without functional mitophagy, would lead to death of the dopami-
nergic neurons. Moreover, since dopaminergic neurons appear to
require increased Parkin function for mitochondrial quality and
functionality more so than other neurons, when the Parkin system
for eliminating damaged mitochondria breaks down and no longer
functions the neurons probably die quickly. The above explanation
does not completely explain the dopaminergic neurons dropout by
PD. The ubiquitin ligase activity of Parkin is also required for the
clearance of some aggregately proteins, for example alpha synuc-
lein [51], Pael-R [52] and Parkin itself, by ubiquitin proteasome sys-
tem [50]. Disruption of turnover or functions of these proteins by
mutated Parkin or PINK1 may also cause the demolition of cell
homeostasis. This possibility also clouds studies on PD pathobiol-
ogy, due to the possibility that dysfunction of protein turnover
may also lead to mitochondrial dysfunctions. However these com-
plex possible mechanisms need to be resolved by future investiga-
tions, we may have good explanations to tackle them based on our
current model of a Parkin-related mitochondrial quality control. As
mentioned above, mitochondria need to be maintained as func-
tional in a cell. When cells accumulate damage (i.e. oxidized pro-
teins, aggregates of misfolded proteins, ROS), mitochondria also
gain a risk of malfunction caused by this damages. Mitochondria
compensate this damage, whereas if damage overwhelms the com-
pensation, cells may have serious problems to keep their function-
ality. Dysfunction of mitochondrial quality control system, such as
impaired Parkin/PINK1 mediated system, also accumulates dam-
aged mitochondria. Then if damaged mitochondria overcome the
healthy mitochondrial network, cells also fall into fatal scenario.
These proposing models may suggest the pathobiology of various
neurodegenerative diseases including PD (Fig. 5).
5. Concluding remarks
Recent progress on neurodegenerative disease and mitochon-
drial dysfunctions are being extended to a variety of scientiﬁc
ﬁelds. Other neurodegenerative disease, such as Alzheimer disease
and Huntington disease, also suggest there is a relationship be-
tween mitochondrial function and the pathobiology mechanisms.Many unsolved issues remain in this ﬁeld. Nevertheless, our ﬁnd-
ings could provide future targets for the therapeutic treatments
of PD as well as other neurodegenerative disorders.
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